Influence of HMG–CoA reductase inhibitors on markers of coagulation, systemic inflammation and soluble cell adhesion
- 1 January 2002
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 82 (1) , 25-31
- https://doi.org/10.1016/s0167-5273(01)00576-9
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive ProteinCirculation, 1999
- Effect of cerivastatin sodium, a new inhibitor of HMG‐CoA reductase, on plasma lipid levels, progression of atherosclerosis, and the lesional composition in the plaques of WHHL rabbitsBritish Journal of Pharmacology, 1999
- Prospective Study of Hemostatic Factors and Incidence of Coronary Heart DiseaseCirculation, 1997
- Reduced platelet aggregation after fluvastatin therapy is associated with altered platelet lipid composition and drug binding to the plateletsBritish Journal of Clinical Pharmacology, 1997
- Reduction of Serum Cholesterol Levels Alters Lesional Composition of Atherosclerotic PlaquesArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Effect of Pravastatin on Outcomes after Cardiac TransplantationNew England Journal of Medicine, 1995
- Leukocyte rolling and extravasation are severely compromised in P selectin-deficient miceCell, 1993
- Reversal of lovastatin‐mediated inhibition of natural killer cell cytotoxicity by interleukin 2Journal of Cellular Physiology, 1990
- Unstable angina. A classification.Circulation, 1989
- Role of mevalonic acid in the regulation of natural killer cell cytotoxicityJournal of Cellular Physiology, 1989